Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma | Zendy

Masami Yamauchi | Zendy; Atsushi Ono | Zendy; Akira Ishikawa | Zendy; Kenichiro Kodama | Zendy; Shinsuke Uchikawa | Zendy; Haruna Hatooka | Zendy; Peiyi Zhang | Zendy; Yuji Teraoka | Zendy; Kei Morio | Zendy; Hatsue Fujino | Zendy; Takashi Nakahara | Zendy; Eisuke Murakami | Zendy; Daiki Miki | Zendy; Tomokazu Kawaoka | Zendy; Masataka Tsuge | Zendy; Akira Hiramatsu | Zendy; Michio Imamura | Zendy; C. Nelson Hayes | Zendy; Masashi Fujita | Zendy; Hidewaki Nakagawa | Zendy; Wataru Yasui | Zendy; Hiroshi Aikata | Zendy; Kazuaki Chayama | Zendy

Open Access

Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Author(s) -

Masami Yamauchi,

Atsushi Ono,

Akira Ishikawa,

Kenichiro Kodama,

Shinsuke Uchikawa,

Haruna Hatooka,

Peiyi Zhang,

Yuji Teraoka,

Kei Morio,

Hatsue Fujino,

Takashi Nakahara,

Eisuke Murakami,

Daiki Miki,

Tomokazu Kawaoka,

Masataka Tsuge,

Akira Hiramatsu,

Michio Imamura,

C. Nelson Hayes,

Masashi Fujita,

Hidewaki Nakagawa,

Wataru Yasui,

Hiroshi Aikata,

Kazuaki Chayama

Publication year - 2020

Publication title -

clinical and translational gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.673

H-Index - 35

ISSN - 2155-384X

DOI - 10.14309/ctg.0000000000000179

Subject(s) - lenvatinib , hepatocellular carcinoma , medicine , fibroblast growth factor receptor 4 , sorafenib , oncology , cancer research , receptor tyrosine kinase , biomarker , cancer , fibroblast growth factor receptor , immunohistochemistry , receptor , biology , fibroblast growth factor , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research